Drugs / DP/MG/14-1
last change Jun 2018 re-read 3 minutes ago

DP/MG/14-1

Developed for
allergic rhinitis
Investigated by
Laboratorios Leti, S.L.

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02340130 Sep 2014 → May 2018 allergic rhinitis, asthma Laboratorios Leti, S.L. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DP/MG/14-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02340130 ↗